ECCO-konferencen i København

Gastroenterologi | Henning Glerup | 11. Apr 2019 kl. 8:32 |

6.-9. marts blev der afholdt ECCO-kongres i Bella Centeret i København. Med 7960 registrerede deltagere var det den hidtil største kongres om inflammatoriske tarmsygdomme. ECCO er en europæisk faglig organisation med betydelig impact på fagområdet. Selve kongressen har ud over det lægefaglige program også selvstændige programmer for blandt andet IBD-interesserede sygeplejersker og diætister. Der er ...

Vedolizumab vs adalimumab in patients with active ulcerative colitis

ECCO 2019 | Best Practice Nordic | 11. Mar 2019 kl. 10:35 |

In this MEDtalk professor Stefan Schreiber present a head-to-head study of the efficacy and safety of vedolizumab and adalimumab for treatment over 52 weeks in adults with moderately to severely active ulcerative colitis (UC). The first study to directly compare two biological agents in IBD. Click and hear the results. ...

Transcriptional profiling of ulcerative colitis in remission

ECCO 2019 | Best Practice Nordic | 9. Mar 2019 kl. 9:54 |

This study addresses whether existing transcriptional profile scan improve and support the current definition of UC in remission apart from the today existing endoscopic, histological and laboratory scoring systems. In this MEDtalk Ruth Paulssen tells og presents that a gut–brain communication network is involved during remission beside the partial restoration of immunological functions and recovery ...

Previous reports have indicated that the treatment of patients with elderly-onset IBD, defined as patients diagnosed ≥60 years, differs from that of younger patients. This study aimed to assess the treatment of elderly-onset IBD during the first 3 years of follow-up, compared with IBD diagnosed in patients aged 15–39 and 40–59, in a European population-based ...

Is there a connection between biomarkers of collagen degradation and formation and disease activity in patients with Crohn’s disease, and can these biomarkers be used in monitoring and prediction of disease activity and in differentiation between patients with CD and healthy individuals? Click and hear Joachim Hoeg Mortensen give the ...

Thiopurine and allopurinol combination therapy is associated with clinical remission in patients with IBD, but its influence on adverse outcomes. In this study Sandra Bohn Thomsen et al. compared patients with IBD treated with thiopurine and allopurinol and patients with IBD treated with thiopurine monotherapy. Click and hear the ...

Crohn’s disease (CD) and ulcerative colitis (UC) carries a high burden on healthcare resources. To date, no study has assessed the combined direct and indirect cost of inflammatory bowel disease (IBD) in a population-based setting. Click and hear the interesting result from a population-based inception cohort with 10 years of follow-up, here presenting by Bobby ...

Patients with inflammatory bowel disease are at risk of developing metabolic bone disease. At the same time no general agreement regarding osteoporosis screening in IBD patients exists. This study shows with 10 years of follow up, that increased attention to IBD patient at risk of metabolic bone disease must be prioritized and guidelines on this ...

This study aimed to compare the real-world clinical effectiveness and safety of vedolizumab, a gut-selective anti-α4β7-integrin, and anti-TNF agents in biologic (bio)-naïve ulcerative colitis (UC) patients. Click and hear the results, presented by Andres Yarur. ...

UC and CD increased the risk of Type 2 Diabetes

ECCO 2019 | Best Practice Nordic | kl. 3:41 |

This Danish population-based cohort study shows an increased risk of T2D both in patients with UC and CD. Whether the significantly higher risk of T2D observed in recent years reflects an impact of current treatment options in IBD remains to be ...

#Seneste udgivelse

Almen praksis

Nr. 2 • maj 2020
14. årgang
  • Type 2-diabetes og hjerte-kar-sygdom
  • Risikogener for ADHD
  • Nye mål for LDL-kolesterol
#

Almen praksis

Bo Gerdes

Bo Gerdes
praktiserende læge

Jens Georg Hansen

Jens Georg Hansen
overlæge, dr.med., speciallæge i almen medicin

  Tina Enevoldsen

Tina Enevoldsen
praktiserende læge